Biodexa Pharmaceuticals PLC

CUSIP 59564R807SPONSORED ADSBDRXQ2 2025

Biodexa Pharmaceuticals PLC — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

6.8%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

2 filings · latest May 28, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	May 28, 2025	Cavalry Fund I LP	13G	6.8%	1.75B	SEC
2	Feb 18, 2025	C/M Capital Master Fund, LP	13G	—	—	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Gamma Investing LLC	11.9K	$10.3K
2	Sbi Securities Co., Ltd.	5.7K	$4.9K
3	Ubs Group AG	2.0K	$1.7K
4	Rhumbline Advisers	69	$59